Skip to main content

Table 11 Four-year changes in Osame motor disability score (OMDS) in the three subgroups classified by interferon-α treatment conditions (n = 148)

From: Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan

 

OMDS change

 

Improved

No change

Worsened

Total

Patients with HAM/TSP without interferon-α treatment during the observation period

2 (1.5%)

86 (65.6%)

43 (32.8%)

131 (100.0%)

Patients with HAM/TSP with at least once interferon-α treatment during the observation period

0 (0.0%)

3 (30.0%)

7 (70.0%)

10 (100.0%)

Patients with HAM/TSP with at least once unknown treatment condition during the observation period

0 (0.0%)

5 (71.4%)

2 (28.6%)

7 (100.0%)

Total

2 (1.4%)

94 (63.5%)

52 (35.1%)

148 (100.0%)